N - 乙转移酶2的单体样型改变了缺脂血症和尿膀癌的风险
1Department of Pharmacology & Toxicology and Brown Cancer Center, University of Louisville School of Medicine, Louisville, Kentucky, USA.
Pharmacogenetics and genomics
|June 12, 2023
概括
一种新发现的N-乙转移酶2 (NAT2) 基因哈普洛型与失脂症和尿膀癌风险有关. 这种非编码区域的遗传变异可能会改变NAT2基因表达,影响疾病易感性.
科学领域:
- 遗传学和基因组学 遗传学和基因组学
- 分子生物学分子生物学
- 癌症研究 癌症研究
背景情况:
- 在N-乙转移酶2 (NAT2) 基因中发现了一种新型的单双原型,包括七种非编码变异,通过全基因组关联研究,独立地与失脂症有关.
- 这种跨基因单基因型位于染色体8上的NAT2编码区域下游大约14kb处.
- 有趣的是,这个相同的NAT2单元型也与尿道膀癌的风险增加有关.
研究的目的:
- 为了研究一种新的NAT2哈普洛型与失脂症和尿膀癌的风险之间的关联.
- 探索这种单双型在NAT2基因表达中的潜在调节作用.
- 了解NAT2活动的变化如何影响这些独特病理的风险.
主要方法:
- 用全基因组关联研究 (GWAS) 来识别新型NAT2单元型及其与脂质障碍症的关联.
- 生物信息分析和链接不平衡映射被用来描述单元型的位置和组成.
- 这项研究推测了作为潜在的远距离调节元件的单元型的功能作用.
主要成果:
- 多个独立的GWAS已经将一个特定的NAT2单元型 (rs1495741,rs4921913,rs4921914,rs4921915,rs146812806,rs35246381和rs35570672) 与失脂症联系起来.
- 同一个NAT2单元型也与尿膀癌的风险增加有关.
- 脱脂症的风险基因与快速化剂表型相关,而膀癌风险基因与缓慢化剂表型相关,表明系统NAT2活性的修饰作用.
结论:
- 鉴定到的NAT2单元型代表了一个重要的遗传因素,影响了对失脂症和尿膀癌的易感性.
- 这种非编码单基因型中的遗传变异可能会调节NAT2基因表达,并可能起到增强剂或消声剂的作用.
- 对这种NAT2单元型的进一步研究可能会导致识别和保护这些疾病风险的个体的策略.
相关概念视频
Genome-wide Association Studies-GWAS
13.6K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
13.6K
Phase II Reactions: Acetylation Reactions
276
Acetylation, a phase II biotransformation reaction, introduces an acetyl group to drugs or their metabolites. Acetyltransferase enzymes facilitate this reaction, which resembles α-amino acid conjugation due to the addition of a functional group to the drug molecule.
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
The substrates for acetylation are typically drugs or their metabolites with an amino, sulfonamide, or hydrazine functional group. Acetylation can occur at several points in the drug molecule, including primary, secondary, and...
276
Phase II Reactions: Glucuronidation
557
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
557
Urinary Tract Infection II: Pathophysiology
20
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
20


